Published March, 2014 in BMC Medicine, a report by AF Macedo et al. titled “Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis.” aimed to “assess unintended effects of statins from observational studies in general populations with comparison of the findings where possible with those derived from randomized trials.”

Statins are class of medications prescribed to treat high cholesterol and have a reliable track record for reducing the risk of adverse cardiovascular events.  Unfortunately, the drugs (such as Lipitor, Zocor, Crestor, and others) have been linked to a 10-30% increased risk for new onset diabetes, another disease affecting millions around the world.

Evaluating 90 different studies of statin side effects, this team determined that “There was evidence of an increased risk of myopathy, raised liver enzymes and diabetes (respectively: OR 2.63 (95% CI 1.50 to 4.61); OR 1.54 (95% CI 1.47 to 1.62); OR 1.31 (95% CI 0.99 to 1.73)).”  In non-scientific terms, this means that statin use raised the risk for myopathy by 163%, raised liver enzymes 54%, and diabetes by 31%.

Sadly, the manufacturer of Lipitor and other statin drugs has failed time and again to warn users of the risks associated with their medication.  As a result, a number of Lipitor lawsuits have been filed.  If you or a loved one used Lipitor and suffered diabetes as a result, you may be entitled to significant financial compensation.  For a free, no-obligation case consultation, contact our team of Lipitor lawyers at the information provided below.  We have the experience, resources, and skills required to win the justice you deserve.  Call today and see how we can help.

(855) 452 – 5529

Our Lipitor Lawsuit Information page is a great place to start if you have any questions about Lipitor.